Delivery Order SPE2DB20D9127-SPE2DB22FD3ZR
Award Date
6/9/22
Potential Completion Date
7/1/22
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $10,720.35 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, titled SPE2DB, allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, a $499,999,999 indefinite delivery contract that provides a range of pharmaceutical products and medical supplies to support the recurring medical needs of U.S. Department of Defense (DoD) healthcare facilities worldwide. The specific award, valued at $85,852.20, is for the delivery of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $41,024.40 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, which has a ceiling value of up to $499,999,999, covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This specific delivery order is for NEXPLANON 68 MG IMPLANTS, with a period of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract has a firm fixed-price pricing type and is for the delivery of NEXPLANON 68 MG IMPLANTS, a pharmaceutical product, to support the recurring medical supply needs of U.S. Department of Defense (DoD) healthcare facilities. The contract has a ceiling value of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The $7,146.90 firm fixed-price delivery order has an ultimate completion date of September 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $7,146.90 for the provision of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) $499,999,999 indefinite delivery contract (IDC) program SPE2DB. The contract, valued at $3,573.45, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of U.S. military health facilities worldwide. The award has a firm-fixed-price pricing type and an ultimate completion date of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order with a ceiling value of $4,288.14. The contract is for the supply of Nexplanon 68 mg implants, a contraceptive product, to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $8,576.28 for the supply of NEXPLANON 68 MG IMPLANTS. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is an indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that runs through December 31, 2025. DMS Pharmaceutical Group holds this single-award IDC to provide a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $1,429.38. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is a multi-year, single-award indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999. The contract is for the delivery of 4566007817 NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of...